SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending after releasing positive Phase 3 trial results for their DMD treatment, showing statistically significant improvement in both skeletal and cardiac function. The community is buzzing about the potential for FDA approval and a possible buyout by a major pharmaceutical company, with many expressing excitement about the implications for treating this rare disease. Short sellers are feeling the squeeze, as the stock experiences high volatility and a surge in trading volume.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as traders weigh potential market volatility amid concerns about Japan's rising bond yields and their impact on global markets. Community discussions revolve around hedging strategies and potential market corrections, with some anticipating a 'black swan' event. Others believe the current market strength is artificial, driven by factors like automated 401k investments, and are positioning for a downturn.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai ($AI) is trending amid discussions around its valuation compared to peers and potential for a short squeeze, as well as speculation about a possible acquisition. Community members are weighing the company's financials and contracts, with some expressing bullish sentiment and others remaining skeptical about its long-term prospects. Option activity and potential price movements are also being closely monitored by traders.

Breaking Bread is a pioneer in Solana meme token designed around a simple and transparent rewards system. With 0% tax on trades, every holder benefits directly from activity without hidden costs or penalties. The token automatically redistributes 100% of creator rewards from Pump.fun back to the community, ensuring fair participation for all holders. The project emphasizes consistency, trust, and community engagement, framing daily “breaking of bread” rewards as both a symbolic ritual and a practical way to sustain value for those who participate.

Breaking Bread

Breaking Bread ($BRBR) is trending due to its innovative approach as a Solana meme coin that rewards holders with $SOL directly, funded by creator rewards and facilitated by zero transaction taxes, which is fueling community excitement and attracting traders seeking real yield. The community is actively discussing the consistent growth, strong floor, and the upcoming feature on CryptoTwits X Spaces, highlighting the project's commitment and potential for long-term gains. Many community members feel this is a refreshing take on meme coins, as it has a true community and rewards for holding.

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

PLRZ is trending due to positive preclinical data for its intranasal naloxone hydrogel, with the community noting its potential as a multi-day runner. Community members are actively discussing price targets and potential short squeezes, drawing comparisons to other low-float Israeli stocks that have recently experienced significant gains. However, some are expressing caution due to the company's history of reverse splits and dilution, as well as an upcoming clinical trial not expected to start until 2026.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending following a partnership announcement with Palantir, integrating their AI platforms. The collaboration aims to enhance data analysis and AI application development, prompting bullish sentiment. Community members are discussing the potential impact on growth, with analysts also weighing in on the partnership's implications.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

SERV is trending as the robotics sector gains attention, fueled by reports of potential government support and media coverage. Community discussions revolve around the stock's overnight price action, high short interest creating squeeze potential, and comparing SERV to other robotics plays like RR and IRBT. Some traders are citing the recent DoorDash partnership as a key catalyst for future growth, while others express concerns about recent price volatility.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending as investors debate its valuation amid mixed sentiment; some see it as deeply undervalued, citing strong fundamentals and buyback programs, while others express frustration with management and the stock's performance relative to competitors and the broader market. The community is closely watching for a potential turnaround and the impact of new initiatives in AI and partnerships, especially with Perplexity, on future growth.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is trending due to the withdrawal of its $6.9 billion offer to acquire Allegro MicroSystems, with community discussion focusing on the implications of this decision. Some view this as a chance for ON to focus on share repurchases, while others question the move and the target company's board's rejection of the offer. The stock is seen as having potential due to its position in power management and sensing solutions, especially in the automotive and industrial markets.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics is trending as investors closely monitor the company's progress towards potential FDA feedback and a possible buyout or partnership. Community discussions highlight positive data readouts and increased excitement from the CEO, fueling speculation about the future of Belapectin. Investors are also paying attention to short positions and trading activity, anticipating a potential short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel drugs in therapeutic areas of infection, cancer and inflammation. Its product candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-aquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. The company was founded by Michael T. Flavin on January 1, 1999 and is headquartered in Woodridge, IL.

ADLS
Advanced Life Sciences Holdings, Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest ADLS News

ADLSAdvanced Life Sciences Holdings, Inc.